G1 Therapeutics Inc
GTHX·Stocks·Pharmaceuticals Major·United States·Nasdaq·USD
Price
$7.16
Today
+0.2%
YTD
+0.1%
About
With headquarters in Research Triangle Park, North Carolina, G1 Therapeutics Inc is a clinical-stage biopharmaceutical company that discovers and develops treatments for cancer. Founded in 2008, the company operates within the US. G1 Therapeutics is listed on NASDAQ GS using the GTHX ticker. Chart GTHX share price changes with the help of your eToro watchlist.
Price chart
Closing price history for GTHX (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-8.30
P/S (TTM)6.45
P/B (TTM)15.32
Market cap$377.22M
Cap tierSmall-cap
Industry avg P/E-7.37
Profitability
Gross margin89.44%
EBIT margin-65.09%
Net margin-33.05%
ROE-109.01%
ROA-36.31%
Earnings & Revenue
Revenue (TTM)$58.20M
Revenue growth (1Y)-34.7%
EPS (TTM)-$0.86
Free cash flow$-37.54M
Total debt$47.96M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.52
Employees100
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.